Faculty Research

dosimetrits looking at a scan

As the state's only academic health center, OHSU's breakthrough research leads to new cures, new standards of care, and a better understanding of the basic science that drives biomedical discovery. OHSU researchers are exploring new basic, clinical, and applied research frontiers. Read about research at OHSU

Interested in Cancer Clinical Trials? OHSU Knight Cancer Institute takes part in hundreds of clinical trials, learn more about participating in a clinical trial.

Support Radiation Medicine

Help drive new discoveries in radiation oncology with a donation to our labs.

Clinical Division

     Chang Lab                           Murphy Lab                                 

     Cook Lab                             Nabavizadeh Group

     Grossberg Lab                  Thompson Lab

     Kahn Lab                              Walker Lab

     Mitin Lab

Radiation Physics Division

     Boopathy Lab                                Junell Lab   

     Heard Lab                                      Kishore Lab                                                                                    


Resident Research

     Anand Lab

     Fuller Lab

     Malhotra Lab

     Nolz Lab

     Raber Lab

     Slatore Lab

     Sun Lab

     Young Lab

The talents and resources of hundreds of individuals, institutions, and industries must be combined to achieve successful diagnosis and treatment of cancer and other diseases.

To help ensure success in the diagnosis and treatment of cancers and diseases, we have developed ongoing relationships with the following institutions:

This collaboration between institutions allows our team to be amongst the first to access any newly researched technologies.

This gives our team a unique opportunity to devise applications for improving the diagnosing of cancers and developing innovative therapeutic treatments. So when you enter our facilities, you can rest assured that the very best minds and machines are devoted to your care.

As part of a teaching institution, the Department of Radiation Medicine's faculty and staff will give presentations both within the department and around the world sharing their knowledge with others studying the field of medicine. Review the department's academic meetings presentations here  

In the news: Radiation Medicine

July 27, 2022

Nima Nabavizadeh, M.D., associate professor and residency program director, is the new PI for the Pathfinder 2 study at OHSU.

Pathfinder 2 is OHSU's largest actively enrolling early cancer detection study using blood samples. The study is seeking volunteers 50 years and older without a known cancer diagnosis. OHSU also has other studies collecting samples from patients receiving routine lung screening with low-dose CT as well as those with a new cancer diagnosis but have yet to receive treatment.

April 29, 2022

Paige Arneson-Wissink, Ph.D. and Beth L. Worley, Ph.D., researchers in Grossberg Lab, presented at the American Association for Cancer Research (AACR) Annual Meeting 2022. Dr. Arneson-Wissink presented data on interleukin-6 derived from tumors impairs the liver’s response to undernutrition in pancreatic cancer cachexia and Dr. Worley detailed how blocking the RNA-binding protein called HuR might provide a new way treat cachexia caused by pancreatic cancer.

Read more here OHSU scientists represent at AACR 

Upcoming Events

2022 Early Detection of Cancer Conference: October 18 - 20, 2022

Leaders in early detection and top scientists and innovators in cancer research and bioengineering will gather in Portland, Oregon, Oct. 18-20, 2022, for the seventh in the series organized by the OHSU Knight Cancer Institute and Cancer Research UK, joined in 2018 by the Canary Center at Stanford.

Pacific Northwest Workshop on Methods in Radiation Oncology Clinical Trials: TBA

The Department of Radiation Medicine and the University of Washington's Department of Radiation Oncology are proud to host the Pacific Northwest Workshop on Methods in Radiation Oncology Clinical Trials. Details available here